Prophylactic treatment of postperfusion bleeding using EACA

• Published in: Chest Vol. 96; no. 1; p. 27
• Main Authors: DelRossi, A J, Cernaianu, A C, Botros, S, Lemole, G M, Moore, R
• Format: Journal Article
• Language: English
• Published: United States 01-07-1989
• Subjects: Aminocaproates - therapeutic use; Aminocaproic Acid - therapeutic use; Blood Transfusion; Cardiac Surgical Procedures; Cardiopulmonary Bypass; Female; Hemostasis, Surgical; Humans; Male; Middle Aged; Myocardial Reperfusion; Postoperative Complications - prevention & control; Premedication; Random Allocation; Time Factors
• ISSN: 0012-3692
• DOI: 10.1378/chest.96.1.27

To determine the effects of prophylactic treatment with EACA for blood loss after cardipulmonary bypass surgery, 350 consecutive patients undergoing open-heart surgery were studied. One hundred seventy patients received an initial dose of 5 g of EACA prior to skin incision, followed by intravenous administration of 1 g/h for the next 6 to 8 h. The control group received saline solution in the same fashion. The EACA-treated group had decreased chest tube blood loss 24 h postoperatively. In addition, EACA-treated patients had fewer myocardial infarctions, cerebrovascular accidents or reoperations for bleeding. Treated patients needed fewer units of blood transfusions than the nontreated group. There was no incidence of hyperthrombotic state or other side effects in the EACA-treated group. We concluded that prophylactic treatment with EACA for open-heart surgery requiring extracorporeal circulation may reduce the total blood loss and the number of blood transfusions in a safe and tolerable manner.